With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity||Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD||Young Investigator Grants||2023||Ohio|
|Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs||Broad Institute / Sean Misek, PhD||Young Investigator Grants||2023||Massachusetts|
|Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors||Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD||Young Investigator Grants||2023||Texas|
|A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia||University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD||Young Investigator Grants||2023||Colorado|
|Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder||The Cleveland Clinic Foundation / Brittany Stewart, PhD||RUNX1 Early Career Investigator Grants||2023||Ohio|
|Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system||The Regents of the University of Michigan / Sriram Venneti, MD/PhD||R Accelerated Award Grants||2022||Michigan|
|Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG||The Regents of the University of Michigan / Meredith Morgan, PhD & Daniel Wahl, MD/PhD||Reach Grants||2022||Michigan|
|Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, MD and Jian Jin, PhD||Innovation Grants||2022||Maryland|
|Molecular circuitry of fibrolamellar carcinoma||Massachusetts General Hospital / Nabeel Bardeesy, PhD||Innovation Grants||2022||Massachusetts|
|Targeted nanoparticle-mediated “cold”-to-“hot” reprogramming of the tumor microenvironment of high-risk neuroblastoma||University of Massachusetts Chan Medical School / Prabhani Atukorale, PhD & Jason Shohet, MD, PhD||Innovation Grants||2022||Massachusetts|